Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2026-03436 | Registry Identifier | CTRP (Clinical Trial Reporting Program) | |
| 2020C0221 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.
PRIMARY OBJECTIVE:
I. To assess the feasibility of utilizing a mobile application for patients to self-track the time burden associated with undergoing pancreatic cancer treatment.
OUTLINE:
Patients download the MyCap app onto their phone and fill out a daily time log in the app for 8 weeks.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Health Services Research (MyCap app) | Experimental | Patients download the MyCap app onto their phone and fill out a daily time log in the app for 8 weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Electronic Health Record Review | Other | Ancillary studies |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Retention rate (feasibility) | Defined as the number of participants who enroll in the study and complete at least one time log during the study period. | Up to 8 weeks |
| Adherence rate (feasibility) | Adherence is defined as the percentage of patients who completed over 80% of time logs. Given that this study is evaluating a daily time log over 8 weeks, adherence would require participants to fill out at least 44-time logs. | Up to 8 weeks |
| System usability survey (feasibility) | Up to 8 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| The Ohio State University Comprehensive Cancer Center | Contact | 800-293-5066 | OSUCCCClinicaltrials@osumc.edu |
| Name | Affiliation | Role |
|---|---|---|
| Pamela W Lu, MD | Ohio State University Comprehensive Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ohio State University Comprehensive Cancer Center | Recruiting | Columbus | Ohio | 43210 | United States |
Not provided
| Label | URL |
|---|---|
| The Jamesline | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Smartphone Application-based Intervention |
| Behavioral |
Receive access to MyCap application |
|
|
| Survey Administration | Other | Ancillary studies |
|